Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBO trial of fractional-dose versus full-dose MVA-BN booster vaccination for mpox
NL-OMON59697Phase 3Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of JYNNEOS in mpox, sponsored by Leiden University Medical Center. Started Jan 2025; status: recruiting.
02
Drugs
JYNNEOS
03
Conditions
mpox
Beyond the preview
Go deeper on NL-OMON59697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59697.